| Financial Year |
March 31 2023 |
| Monetary Funds |
141,231,674.91 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
176,316,089.22 |
| Advances to Suppliers |
539,125,246.93 |
| Other Receivables |
5,587,663.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,023,313,278.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,739,615.57 |
| Total Current Assets |
1,926,313,568.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,578,957.99 |
| Investment Properties |
-- |
| Fixed Assetes |
3,917,110.84 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
183,441.06 |
| R&D expenses |
-- |
| Goodwill |
4.82 |
| Long-Term Deferred and Prepaid Expenses |
5,123,502.66 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
44,965,849.01 |
| Total Assets |
1,971,279,417.23 |
| Short-Term Loans |
320,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
62,753,544.98 |
| Accounts Received In Advance |
167,076,763.55 |
| Employee Compensation Payable |
3,339,142.09 |
| Taxes Payable |
3,513,250.35 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,244,781,856.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,775,787.57 |
| Other Current Liabilities |
533,576.42 |
| Sub-Total of Current Liabilities |
1,883,569,763.33 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
425,900.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
27,371,137.33 |
| Total Liabilities |
1,910,940,900.66 |
| Paid-In Capital(Or Share Stock) |
409,004,600.00 |
| Capital Surplus |
132,167,131.78 |
| Surplus Reserve |
32,849,779.83 |
| LESS:Treasury Stock |
31,045,844.00 |
| Undistributed Profits |
-422,086,935.85 |
| Minority Stockholder's Interest |
-43,397,126.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
103,735,642.78 |
| Owner's Equity（Stockholder's Equity） |
60,338,516.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,971,279,417.23 |
